Oluseye Oladotun Bolaji (O O Bolaji, Ayorinde Adehin, Oluseye O Bolaji, Oluseye Bolaji)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 11

Top Venues

Wellcome open research

Drug metabolism and personalized therapy

Leukemia & lymphoma

AAS open research

Obafemi Awolowo University Faculty of Pharmacy

University of Strathclyde (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Obafemi Awolowo University Faculty of Pharmacy

Nigeria

Professor :: Pharmaceutical Chemistry

Obafemi Awolowo University Faculty of Pharmacy

Nigeria

Reader :: Pharmaceutical Chemistry

Obafemi Awolowo University Faculty of Pharmacy

Nigeria

Senior Lecturer :: Pharmaceutical Chemistry

King Fahd Medical Research Center

Saudi Arabia

Research Scientist :: Drug Monitoring Unit

University of Alberta

Canada

Research Associate :: Pharmaceutical Sciences

Obafemi Awolowo University Faculty of Technology

Nigeria

Lecturer I :: Pharmaceutical Chemistry

Obafemi Awolowo University Faculty of Pharmacy

Nigeria

Graduate Assistant :: Pharmaceutical Chemistry

Education History

University of Strathclyde

United Kingdom

PHD :: Pharmacy

Obafemi Awolowo University

Nigeria

MSC :: Pharmaceutical Chemistry

Obafemi Awolowo University

Nigeria

BSC :: Pharmacy

Publications

Oluwasegun Ibrahim Eniayewu, Uche Azuka, Jonah Ogah, Ebunoluwa A Adejuyigbe, Oluseye Oladotun Bolaji, Adeniyi Olagunju
Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum. Clinical pharmacology and therapeutics (2024)
Adeniyi Olagunju, Jacinta Nwamaka Nwogu, Oluwasegun Eniayewu, Shakir Atoyebi, Alieu Amara, John Kpamor, Oluseye Oladotun Bolaji, Ebunoluwa Adejuyigbe, Andrew Owen, Saye H Khoo
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry. Wellcome open research 6 (2022)
Adeniyi Olagunju, Jacinta Nwamaka Nwogu, Oluwasegun Eniayewu, Shakir Atoyebi, Alieu Amara, John Kpamor, Oluseye Oladotun Bolaji, Ebunoluwa Adejuyigbe, Andrew Owen, Saye H Khoo
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry. Wellcome open research 6 (2022)
Adeniyi Olagunju, Jacinta Nwamaka Nwogu, Oluwasegun Eniayewu, Shakir Atoyebi, Alieu Amara, John Kpamor, Oluseye Oladotun Bolaji, Ebunoluwa Adejuyigbe, Andrew Owen, Saye H Khoo
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry. Wellcome open research 6 (2021)
Ayorinde Adehin, Martin Alexander Kennedy, Julius Olugbenga Soyinka, Olusegun Isaac Alatise, Olalekan Olasehinde, Oluseye Oladotun Bolaji
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy. Breast cancer (Dove Medical Press) 12 (2020)
Oluseye Oladotun Bolaji, Ayorinde Adehin, Babatunde A Adeagbo
Pharmacogenomics in the Nigerian population: the past, the present and the future. Pharmacogenomics 20 (12) (2020)
Collet Dandara, Collen Masimirembwa, Yosr Z Haffani, Bernhards Ogutu, Jenniffer Mabuka, Eleni Aklillu, Oluseye Oladotun Bolaji, null null
African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa. AAS open research 2 (2019)
Ayorinde Adehin, Babatunde Ayodeji Adeagbo, Martin Alexander Kennedy, Oluseye Oladotun Bolaji, Tiwalade A Olugbade, Rahman A Bolarinwa, Muheez A Durosinmi
Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients? Leukemia & lymphoma 60 (1) (2018)
O S Olawoye, Babatunde Ayodeji Adeagbo, Oluseye Oladotun Bolaji
Moringa oleifera leaf powder alters the pharmacokinetics of amodiaquine in healthy human volunteers. Journal of clinical pharmacy and therapeutics 43 (5) (2018)
Ayorinde Adehin, Oluseye Oladotun Bolaji, Simran Maggo, Martin A Kennedy
Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population. Drug metabolism and personalized therapy 32 (1) (2017)
Oluseye Oladotun Bolaji, Oluseye O Bolaji
Polymorphisms of CYP1A2 and CYP2A6 activity: phenotypes and the effect of age and sex in a Nigerian population. Drug metabolism and personalized therapy 30 (3) (2016)

Oluseye Oladotun Bolaji.css-eqlu8i{font-size:small;padding-left:4px;} (O O Bolaji, Ayorinde Adehin, Oluseye O Bolaji, Oluseye Bolaji)

Publication Activity (10 Years)

Top Topics

Top Venues

Oluseye Oladotun Bolaji (O O Bolaji, Ayorinde Adehin, Oluseye O Bolaji, Oluseye Bolaji)